Purpose While factors leading to hypoventilation have been well studied in Pompe disease, cough effectiveness and airway clearance practices are less understood. We aimed to identify significant factors that influence peak cough flow (PCF) in Pompe, and to detect whether pulmonary hygiene practices were reflective of reduced PCF. Methods This is a prospective observational study of 20 subjects with Pompe disease (infantile-onset: 7, juvenile-onset: 6, adult-onset: 14). Subjects performed spirometry, maximal respiratory pressures, and cough (voluntary: n = 24, spontaneous: n = 3). Subjects or their parents reported airway clearance and secretion management practices. Relationships between disease variables, pulmonary function, and cough parameters as well as group differences in cough parameters were evaluated. Results Subjects with infantile-onset disease had significantly lower PCF (p < 0.05) and tended to require more external ventilatory support (p = 0.07). In juvenile-and adult-onset disease, PCF differed according to external ventilatory requirement [daytime: 83.6 L/min (95% CI 41.2-126.0); nighttime: 224.6 L/min (95% CI 139.1-310.2); none: 340.2 L/min (95% CI 193.3-487.6), p < 0.005]. Cough inspiratory volume also differed significantly by ventilatory requirement [daytime: 5.5 mL/kg (95% CI 3.0-8.0); nighttime: 16.0 mL/kg (95% CI 11.8-20.2); none: 26.8 mL/kg (95% CI 11.9-41.7), p < 0.001]. However, routine airway clearance or secretion management practices were only consistently reported among patients with infantile-onset disease (infantile: 86%, juvenile: 0%, adult: 14%, p < 0.005). Conclusions Cough weakness was detected in the majority of patients with Pompe disease and was influenced by both inspiratory and expiratory muscle function. Patients at risk for problems or with ineffective PCF should be urged to complete routine pulmonary hygiene.
Introduction
Pompe disease is an inherited neuromuscular disease caused by mutations in the gene encoding acid alpha-glucosidase (GAA). Deficiency of GAA impairs the disassembly of lysosomal glycogen, and subsequently leads to glycogen accumulation in the internal organs, muscle, and neural tissues. The Pompe phenotype corresponds to residual GAA activity and can range from a rapidly progressive, severe infantile form to a later-onset, milder phenotype in which symptoms progress over years to decades [1, 2] . Across the phenotypic continuum, Pompe is characterized by respiratory weakness that leads to sleep disordered breathing, ineffective airway clearance, and progressive ventilatory insufficiency [3] . The consequences are costly, and respiratory problems are the primary contributor to morbidity and mortality [4] .
While effects of respiratory muscle weakness on hypoventilation are well documented for Pompe disease [5] , impacts on airway clearance dysfunction and pulmonary hygiene practices are less clear. Clinically, the adequacy of a cough can be evaluated in a rapid, non-invasive manner by measuring peak airflows generated during the cough (PCF). In adults with other neuromuscular conditions, PCF values below ~ 160 L/min predicted an inability to extubate or decannulate [6, 7] . Additionally, a voluntary PCF between 160 and 270 L/min was associated with elevated risk for ineffective cough during respiratory illness [8] . These threshold values have been recommended as the basis for prescribing cough assistance therapies in Pompe disease [3] .
Prior studies reported impaired cough strength in some patients with Pompe disease [9] . However, detailed evaluation of the relationships between the strength and timing of voluntary cough has not been completed. Further, it is not known whether the actual pulmonary hygiene practices of patients with Pompe disease correspond to published airway clearance guidelines [3] . Therefore, the purposes of this study were to evaluate factors that influence PCF in Pompe disease and to identify whether the proposed threshold PCF values corresponded to the airway clearance practices of the sample.
Materials and Methods

Subjects
Cough was evaluated in participants of two observational research studies of individuals with Pompe disease. The University of Florida Institutional Review Board reviewed and approved the study procedures (IRB #2016-0161, #2017-0087), which met standards set forth in the Helsinki Declaration. Individuals diagnosed with Pompe disease by genetic testing or enzyme activity assays were eligible to participate. Inclusion criteria included the ability to sit with support and the ability to breathe spontaneously without assisted ventilation for at least 1 min. Subjects or their designated guardians provided written informed consent, and school-aged children assented to participate.
Exclusionary criteria included (1) diagnosis of other neurological disorders (e.g., Parkinson's disease, stroke), (2) current or recent (≤ 30 days) respiratory infection, (3) current or recent (≤ 14 days) use of corticosteroid or antibiotic medications, (4) pregnancy, (5) recent surgery (≤ 30 days), or (6) uncontrolled hypertension.
Test Procedures
Tests included clinical pulmonary function tests (PFTs: spirometry, maximal respiratory pressures) and voluntary (n = 24) or spontaneous (n = 3) cough recordings. Test procedures were completed in a quiet clinic room with the participant seated upright with the back supported. When a tracheostomy was present, tests were completed via the tracheostomy tube with cuff inflated. For cuffless tracheostomies, subjects closed their mouth and wore a nose clip to minimize leaks through the upper airway.
Spirometry
Upright forced vital capacity (FVC) tests were conducted in accordance with ATS/ERS guidelines [10] , using a filtered adaptor connected to a spirometer (KoKo, NSpire). After three to five tidal breaths, subjects inhaled to total lung capacity, followed by a sustained maximal forced exhalation to residual volume. Subjects received encouragement to provide a maximal effort. FVC tests were repeated until three efforts within 5% were obtained, and the best effort was reported.
Maximal Respiratory Pressures
Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were tested with a filtered adaptor according to recommended guidelines [11] . Subjects used a digital manometer (Micro RPM, Care Fusion) placed in series with a disposable mouthpiece and filter. MIP was a 3-s, maximal static inspiratory contraction from residual volume. MEP was a 3-s, maximal static expiratory contraction from total lung capacity, with the oral muscles stabilized by the tester. Measurements were repeated three to five times with 20-30 s between attempts, to achieve three trials with < 5% variation. Of these, the best effort was recorded.
Voluntary Cough
Most participants completed 3-5 voluntary cough tests using a facemask. In tracheostomized participants, cough test equipment was connected directly to the tracheostomy tube. After ~ 4-6 tidal breaths, participants were instructed to take a deep breath and cough as forcefully as possible, "as if something went down the wrong pipe." Three participants were not old enough to follow instructions for voluntary cough. However, during sustained recordings of unassisted tidal breathing, each generated at least three technically acceptable spontaneous coughs in an attempt to expel mucus from the airway.
Cough data were collected using a heated pneumotachograph (HR 3500B, 3700B, or 3813 Hans Rudolph, Shawnee, KS). The differential pressure signal from the pneumotachograph was transmitted to a digital spirometer and data acquisition system (S30-16, ADInstruments, Boston, MA) and recorded with a laptop computer. Data were sampled at 1 kHz and low-pass filtered at 40 Hz.
Pulmonary Hygiene Practices
Patients or their caretakers were interviewed to determine the type and frequency of pulmonary hygiene practices they employed. Cough augmentation included techniques to enhance a subject's cough force, such as manually assisted exhalation/cough, assisted insufflation (volitional or assisted), or the use of mechanical insufflation-exsufflation devices [12] . Secretion removal incorporated techniques to loosen and remove mucus from the airways such as manual chest physiotherapy, postural drainage, high-frequency chest wall oscillation, intrapulmonary ventilation, and suctioning [12] . Participants rated the frequency of each practice as routine (three or more days per week), occasional (only as needed and not more often than twice weekly), or not used.
Data Analysis
Cough data were analyzed off-line using Lab Chart Pro v7.2 (ADInstruments, Colorado Springs). The following cough parameters were measured: inspiratory phase peak flow, inspiratory phase duration, cough inspiratory volume, compression time, peak cough flow (PCF) (i.e., expiratory phase peak flow), expiratory phase rise time, cough volume acceleration (defined as PCF/expiratory phase rise time), cough expiratory volume, expiratory phase duration, and the number of cough expiratory efforts per cough epoch (Fig. 1) . Each parameter was averaged from the subject's three best efforts.
Subjects were classified according to their clinical presentation (infantile-, juvenile-, or adult-onset) [2, 13] , requirement for assisted ventilation [no support, nighttime support (invasive or non-invasive), or daytime support (invasive or non-invasive)], and cough effectiveness according to neuromuscular guidelines for adults (normal: > 270 L/min, at risk: 160-270 L/min, ineffective: < 160 L/min).
The distribution of the demographic data was tested, and group differences were analyzed with parametric or non-parametric ANOVA. Relationships between disease variables, pulmonary function, and cough parameters were evaluated with Pearson's correlation. Statistical analysis was completed with SPSS v24.0, using a significance threshold of p < 0.05. For non-normal distributions, median (interquartile range, IQR) is reported; otherwise means ± standard deviations (SD) or 95% confidence intervals are reported.
Results
Effect of Age on Cough
PCF was obtained from 27 patients (infantile-onset: n = 7, juvenile-onset: n = 6, adult-onset: n = 14), ranging in age from 1 to 70 years (Table 1) . Subjects with the infantile phenotype tended to use ventilatory support for a greater proportion of the day [median (IQR) infantile: 24 (8-24) Fig. 1 The examples illustrate differences in cough magnitude in a a juvenile-onset patient with normal peak cough flow (patient 2) and in b an adultonset patient with marginal peak cough flow who uses daytime non-invasive ventilation (patient 18). A cough epoch consists of a cough inspiration followed by the associated expulsive efforts, and it includes (A) cough inspiratory volume/duration, (B) inspiratory phase peak flow, (C) compression phase duration, (D) expiratory phase rise time, (E) peak cough flow, (F) cough expiratory volume/duration, and (G) total expiratory duration h, juvenile: 4 (0-13) h, adult: 9 (8-12.75) h, Kruskal-Wallis, p = 0.07], and they were more likely to be tracheostomized (infantile: 57%, juvenile: 0%, adult: 8%, Chi square, p < 0.05). Due to their smaller stature and more severe clinical presentation, PCF was significantly lower for infantile-onset subjects (50.8 ± 29.7 L/min, juvenile-onset: 202.7 ± 142.7 L/min, adult-onset: 209.1 ± 126.1 L/min, ANOVA, p < 0.05). In contrast, pulmonary function and PCF were not different between juvenile-and adult-onset patients. Further, cough assistance or secretion management was more frequently used in infantile patients (infantile: 86% routine, 14% occasional; juvenile: 0% routine, 33% occasional; adult: 14% routine, 29% occasional; Chi square, p < 0.005). Subsequent analyses focused on the juvenile-and adult-onset groups.
Among juvenile-and adult-onset patients, linear relationships between PCF and pulmonary function testing outcomes were strongly significant ( Table 2) . PCF had strong positive correlations with inspiratory volume (r = 0.72) and expiratory volume (r = 0.71), as well as moderate positive correlations with peak inspiratory flow (r = 0.66) and inspiratory time (r = 0.65).
Effect of Ventilatory Assistance on Cough
Among juvenile and adult-onset subjects, one newly diagnosed patient was excluded, pending pulmonary and sleep medicine consults. For the remaining subjects, we detected differences in cough, based upon their requirement for external ventilation (Fig. 2) . PCF was significantly reduced in subjects who required daytime ventilatory support (83. 
Pulmonary Hygiene Practices
Among the juvenile and adult-onset patients, nine had an ineffective cough (PCF < 160 L/min), five were at risk (PCF 160-270 L/min), and cough PCF was normal (PCF > 270 L/ min) in six [3] . None of the patients with normal PCF utilized secretion management, and one-third used occasional airway clearance. In those at risk for cough problems, none used secretion management strategies, and airway clearance was occasional (n = 1) or not practiced (n = 4). While a majority of patients with ineffective cough used airway clearance (routine: n = 1, occasional: n = 6), two reported no use. Four patients with ineffective cough reported routine use of secretion management, one used it occasionally, and four denied using secretion management.
Discussion
Here we report new findings that PCF generated by a majority of the adolescent and adult Pompe disease sample was ineffective or associated with an increased risk for respiratory problems during illness [6, 8] . Effectiveness of the PCF in the sample differed based upon the requirement for ventilatory assistance. The requirement for ventilatory assistance also distinguished the inspiratory and expiratory volumes generated during the cough maneuver. The majority of patients with reduced PCF did not report routine use of cough assistance or secretion management. In addition, this study reports novel data of PCF in patients with infantileonset Pompe disease and in tracheostomized patients. Published considerations for managing respiratory muscle weakness in Pompe disease include annual monitoring of spirometry, maximal respiratory pressures, and PCF [3] . For stable patients whose best PCF is < 270 L/min on one occasion, airway clearance and secretion management techniques should be instructed for use as needed, while patients with ineffective cough should incorporate airway clearance and secretion management into their daily routine [3] . In this sample, the requirement for ventilatory support also distinguished cough efficacy. Despite some variability, patients who required nighttime support generated an average PCF that placed them at risk for airway clearance problems. Therefore, a positive sleep study or new prescription for nighttime ventilation may necessitate a PCF evaluation. Assisted airway clearance techniques can improve PCF [14] , yet many adolescent and adult subjects with reduced PCF reported no pulmonary hygiene routine. We acknowledge that some patients may disregard the clinical recommendations and equipment distributed by their local providers. For example, some subjects reported owning an airway clearance device they did not use, because it was uncomfortable or required a large time commitment. However, when airway clearance devices and training are available to patients with neuromuscular disease, habitual use is a reasonable goal [15] . The only significant difference in cough timing was the inspiratory phase duration of independently breathing subjects (f), which was significantly longer than the groups who used support. PCF and cough volume acceleration were significantly correlated with the magnitude of the inspiratory phase. During cough, inspiratory muscle contractions inflate the lungs toward inspiratory capacity. Larger inhaled volumes increase pulmonary elastic recoil and improve the lengthtension of the expiratory muscles [16] . Cough inspiratory volume best differentiated patients according to their external ventilatory requirement. Early, preferential diaphragmatic paresis is a hallmark of Pompe disease [17, 18] , and diaphragm dysfunction impacts PCF as well as ventilation [19] . Our results are consistent with previous reports that larger cough inspiratory volumes, whether through voluntary effort, air stacking, or assisted insufflation, generate significantly higher PCF [20, 21] . Although cough inspiratory and expiratory volumes differed according to respiratory muscle weakness and ventilator use, the timing of cough was stable until subjects required daytime support. This suggests that, while respiratory motor neuron loss occurs in Pompe disease [22] , neural dysfunction did not alter coordination of the voluntary cough motor program until patients developed severe hypoventilation.
Technical Considerations
The sample included four children and two adults with a tracheostomy. PCF of the single tracheostomized adult who used nighttime support (subject 27) was below the published threshold for ineffective cough, along with two other noninvasively supported nighttime users. Glottic closure is not a requirement for cough, but its absence negatively impacts cough strength [23, 24] and decannulation or tracheostomy capping significantly increases PCF [25] . The sample of adults was too small to separately evaluate the effect of tracheostomy on cough timing and magnitude, but this issue warrants further study.
We report a lower PCF than some studies [26] . Patients with lower baseline function were eligible for the current study. Results may also have been affected by the use of the facemask. The chamber created by the facemask acts as a low-pass filter potentially reducing the peak expiratory flows, similar to a muffler on a car [27] . A facemask is preferred in patients with bulbar muscle involvement [28] , and recent consensus guidelines recommend a facemask for PCF testing in neuromuscular disease [12] .
While infantile-onset PCFs fell well below median ageand gender-matched reference values for children [29] , subjects < 14 years of age were not included in the detailed cough analyses. Cough efficacy thresholds were largely derived in adults [6] . It appears that PCF < 160 L/min places children at risk for chest infections [30] , but definitive efficacy thresholds are not validated in pediatric neuromuscular disorders [31] . We observed that, despite the severe phenotype of the infantile-onset patients, all could voluntarily or spontaneously initiate a cough. Three children were extremely young, and spontaneous coughing was incidentally recorded during monitoring of tidal breathing. Pressures generated during a spontaneous cough are less forceful than maximal voluntary efforts [32] , which may also have influenced the PCF and corresponding volumes in the infantile sample. Therefore, we urge against generalizing these results to pediatric neuromuscular disease.
Conclusions
In this sample, the majority of patients with juvenile-and adult-onset Pompe disease had a PCF that placed them at risk for airway clearance problems, yet relatively few incorporated pulmonary hygiene into their daily routine. Since the inspiratory phase of cough and use of ventilatory support significantly impacted PCF, changes in inspiratory muscle function or ventilator use should trigger a comprehensive evaluation of cough effectiveness. Further study is needed to establish PCF values associated with risk for airway clearance problems in pediatric patients with Pompe disease.
